Endeavour Vision
Endeavour Vision is a growth-stage investor that invests in growth-stage medtech and digital health companies in Europe and the US.
Business Model:
Revenue: $4.9M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Endeavour Vision Information
Geographic Data
Address: 6 rue de la Croix d’Or
City: Geneva
State: geneva
Zip: 1204
Country: CH
Financial Info
Stage:
Raised Last:
$0
Raised Total:$650M
Social
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Endeavour Vision is a leading private equity firm investing in growth-stage MedTech and digital health companies. We invest in medical innovation that provides superior clinical benefits for patients or brings significant efficiencies to health systems. Our team offers strategic and operational expertise and extensive international experience investing in companies in Europe and North America. We have a proven track record of successful exits with recently realized investments that include Vertiflex (acquired by Boston Scientific in 2019), Medartis (IPO on SIX in Q1 2018), and Symetis (acquired by Boston Scientific in 2017). Endeavour Vision’s offices are located in Geneva, Switzerland, and Minneapolis, U.S.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2021 | INBRACE | Series D | 0 |
| 9/2008 | CommProve | Venture Round | 14M |
| 1/2010 | CeQur | Series A | 29.6M |
| 9/2020 | V-Wave | Series C | 0 |
| 7/2014 | SOPHiA GENETICS | Series B | 0 |
| 3/2017 | VertiFlex | Equity | 45.3M |
| 9/2015 | CeQur | Series C | 100M |
| 6/2009 | Lumavita | Series A | 5.5M |
| 3/2023 | Relievant Medsystems | Series G | 0 |
| 3/2008 | Retailo | Series B | - |
| 2/2012 | Amplidata | Series C | 8M |
| 9/2010 | Amplidata | Series B | 6M |
| 2/2011 | Retailo | Series C | - |
| 3/2006 | Endoart | Series C | - |
| 6/2020 | Polares Medical | Series B | 0 |
| 9/2010 | Nfocus Neuromedical | Series C | - |
| 6/2018 | Relievant Medsystems | Series E | 58M |
| 10/2020 | SOPHiA GENETICS | Series F | 0 |
| 10/2010 | Symetis | Series C | 0 |
| 4/2011 | Kobojo | Series A | 7.8M |
| 8/2007 | Retailo | Series A | - |
| 10/2022 | HealthJoy | Series D | 0 |
| 8/2015 | ReShape Lifesciences | Post-IPO Equity | 38M |
| 4/2005 | CXignited | Venture Round | 12.2M |
| 5/2020 | Rapid Micro Biosystems | Private Equity Round | 0 |
| 7/2018 | Polares Medical | Series A | 0 |
| 7/2015 | Gynesonics | Venture Round | 43M |
| 4/2021 | CeQur SA | Series C | 0 |
| 7/2011 | Quid | Series C | 24M |
| 5/2015 | Kobojo | Series B | 7M |
| 1/2011 | PneumRx | Venture Round | 0 |
| 10/2012 | Spartoo | Series C | 32.4M |
| 1/2010 | Spartoo | Series B | 17.4M |
| 3/2010 | CXignited | Series D | 0 |
| 2/2019 | Nuvaira | Equity | 79M |
| 5/2012 | Symetis | Series D | - |
| 1/2023 | Venture Med Group | Convertible Note | - |
| 1/2018 | Gynesonics | Private Equity Round | 75M |
| 5/2016 | EndoStim | Series D | 25M |
| 8/2020 | Lumeon | Series D | 0 |
| 5/2006 | CXignited | Series C | 0 |
| 11/2021 | Virtual Incision | Series C | 0 |
| 8/2017 | Venture Med Group | Series B | 15M |
| 3/2014 | Amplidata | Series D | 11M |
| 9/2012 | Amplidata | Venture Round | 6M |
| 5/2012 | OncoEthix | Series A | 4.6M |
| 4/2022 | IntelyCare | Series C | 0 |
| 11/2021 | Venture Med Group | Convertible Note | - |
| 2/2022 | Nalu Medical | Venture Round | 0 |
| 1/2011 | SmallRivers | Series A | 2.1M |
| 12/2009 | Molecular Partners | Series B | 44.2M |
| 9/2016 | Chrono Therapeutics | Series B | 47.6M |
| 2/2020 | IntelyCare | Series B | 45M |
| 10/2020 | Relievant Medsystems | Venture Round | 0 |
| 6/2010 | BIND Therapeutics | Series C | 12.4M |
| 12/2021 | Kenbi | Series A | 0 |
| 8/2007 | Molecular Partners | Series A | 15.6M |
| 12/2013 | Quid | Convertible Note | 3.5M |
| 1/2023 | Miach Orthopaedics | Series B | 0 |
| 8/2013 | OncoEthix | Series B | 0 |
| 4/2021 | Willow | Series C | 26.8M |
| 4/2018 | V-Wave | Series C | 0 |
| 4/2022 | IntelyCare | Series C | 0 |
| 2/2022 | Nalu Medical | Venture Round | 0 |
| 12/2021 | Kenbi | Series A | 0 |
| 11/2021 | Virtual Incision | Series C | 0 |
| 11/2021 | Venture Med Group | Convertible Note | - |
| 9/2021 | INBRACE | Series D | 0 |
| 4/2021 | Willow | Series C | 0 |
| 4/2021 | CeQur | Series C | 0 |
| 10/2020 | Relievant Medsystems | Venture Round | 0 |
| 10/2020 | SOPHiA GENETICS | Series F | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
